Physician profile
Farris Jackson
NPI 1083618904
$2,902.25
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $510 · 2021: $518 · 2022: $783 · 2023: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $915.11 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $649.80 | 2019-2023 | Breztri, Symbicort |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.10 | 2019-2023 | Spiriva Respimat |
| Genzyme Corporation | $136.48 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $131.67 | 2019-2022 | |
| Mylan Specialty L.P. | $119.12 | 2019-2023 | Yupelri |
| Philips North America LLC | $97.04 | 2019-2023 | |
| Genentech USA, INC. | $89.45 | 2019-2021 | |
| Boston Scientific Corporation | $75.54 | 2022 | |
| Vapotherm INC | $55.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.17 | 2020-2021 | |
| Insmed, INC. | $35.35 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $32.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $32.49 | 2019 | |
| Natus Medical Incorporated | $28.17 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $23.47 | 2021 | |
| Baxter Healthcare | $22.53 | 2022 | |
| Merck Sharp & Dohme LLC | $22.02 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.61 | 2022 | |
| Grifols USA, LLC | $15.30 | 2019 | |
| Shire North American Group INC | $14.00 | 2019 | |
| Covis Pharma Gmbh | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farris Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.